We are live on
!
Find out more
SCM
Shelton Capital Management Portfolio holdings
AUM
$4.57B
1-Year Est. Return
32.26%
This Fund
S&P 500
This Quarter
Est. Return
+10.16%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$661M
AUM Growth
+$63.6M
(+11%)
Cap. Flow
+$8.57M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
777
New
87
Increased
152
Reduced
160
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axos Financial
AX
|
+$1.14M |
| 2 |
Intercontinental Exchange
ICE
|
+$1.1M |
| 3 |
Exelixis
EXEL
|
+$1.1M |
| 4 |
Tesla
TSLA
|
+$1.09M |
| 5 |
Intel
INTC
|
+$582K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$3.57M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$1.62M |
| 3 |
CELG
Celgene Corp
CELG
|
+$1.59M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$1.54M |
| 5 |
Ametek
AME
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.89% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.41% |
| 4 | Industrials | 10.23% |
| 5 | Energy | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Dick's Sporting Goods
DKS
$18.1B
| $632K | 0.1% |
10,881
| – | – |
|
227
MDU Resources
MDU
$4.32B
| $631K | 0.1% |
54,357
-1,591
| -3% | -$17.9K |
|
228
Netflix
NFLX
$309B
| $630K | 0.1% |
119,700
+20,650
| +21% | +$101K |
|
229
TotalEnergies
TTE
$194B
| $629K | 0.1% |
6,498,194,436
| – | – |
|
|
VAL
230
DELISTED
Valspar
VAL
| $629K | 0.1% |
8,823
-466
| -5% | -$32.3K |
|
231
Alliant Energy
LNT
$18.2B
| $627K | 0.09% |
24,288
-728
| -3% | -$18.8K |
|
232
Occidental Petroleum
OXY
$58.5B
| $627K | 0.09% |
6,881
| – | – |
|
|
CBST
233
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $627K | 0.09% |
9,100
+4,555
| +100% | +$295K |
|
234
Pinnacle West Capital
PNW
$12.2B
| $625K | 0.09% |
11,806
| – | – |
|
235
Kirby Corp
KEX
$7.18B
| $624K | 0.09% |
6,292
| – | – |
|
|
WFM
236
DELISTED
Whole Foods Market Inc
WFM
| $621K | 0.09% |
10,738
+1,560
| +17% | +$92.5K |
|
237
Eli Lilly
LLY
$1.09T
| $618K | 0.09% |
12,119
-900
| -7% | -$45.1K |
|
238
RPM International
RPM
$14.7B
| $614K | 0.09% |
14,789
| – | – |
|
239
Idexx Laboratories
IDXX
$45B
| $612K | 0.09% |
11,502
-620
| -5% | -$32.6K |
|
|
SLXP
240
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $612K | 0.09% |
+6,800
| New | +$542K |
|
241
Toll Brothers
TOL
$13.9B
| $611K | 0.09% |
16,521
| – | – |
|
|
WDR
242
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $611K | 0.09% |
9,381
-262
| -3% | -$16K |
|
243
NCR Voyix
VYX
$1.12B
| $607K | 0.09% |
29,073
| – | – |
|
244
Reinsurance Group of America
RGA
$16.1B
| $601K | 0.09% |
7,770
-497
| -6% | -$36.2K |
|
245
SM Energy
SM
$7.71B
| $600K | 0.09% |
7,223
| – | – |
|
246
Arrow Electronics
ARW
$10.7B
| $595K | 0.09% |
10,966
-806
| -7% | -$41K |
|
247
Molson Coors Class B
TAP
$7.75B
| $595K | 0.09% |
+10,600
| New | +$567K |
|
248
Pediatrix Medical
MD
$2.15B
| $591K | 0.09% |
11,064
| – | – |
|
|
EXXI
249
DELISTED
ENERGY XXI LTD COM SHS
EXXI
| $591K | 0.09% |
21,835
| – | – |
|
|
WCN
250
Waste Connections
WCN
$41.6B
| $590K | 0.09% |
20,274
-554
| -3% | -$16.2K |
|
Similar funds
SV
LNWTC
VCM
ACM
JRP
MA
GIBU
EI
Shelton Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Shelton Capital Management held 777 positions worth $661M, up 11% from $598M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Shelton Capital Management's Q4 2013 filing shows 87 new, 152 increased, 160 reduced and 27 closed positions. Its largest new stake was Axos Financial: 63,596 shares worth $1.25M. The largest sale was BioMarin Pharmaceuticals, an estimated $3.57M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Shelton Capital Management's largest Q4 2013 buy was Axos Financial: 63,596 shares worth $1.25M.
- Shelton Capital Management added most to Tesla in Q4 2013, an estimated $1.09M increase.
- Shelton Capital Management's biggest Q4 2013 reduction was BioMarin Pharmaceuticals, cutting an estimated $3.57M.
- Shelton Capital Management fully exited Ametek in Q4 2013, selling an estimated $1.25M.
- Shelton Capital Management's ten largest holdings make up 17% of its $661M portfolio in Q4 2013.
- Shelton Capital Management opened 87 new positions and closed 27 in Q4 2013.
- Shelton Capital Management's portfolio value rose 11% quarter-over-quarter to $661M.
Based on Shelton Capital Management's 13F filing for Q4 2013, filed 22 Jan 2014.